等待开盘 08-01 09:30:00 美东时间
-0.140
-4.90%
Autonomix Medical, Inc. has entered into agreements with certain warrant holders to exercise or prepaid warrants for up to 1,477,596 shares at $1.723 per share, generating approximately $2.5 million in gross proceeds. New unregistered warrants will be issued, exercisable for the same number of shares at the same price, valid for five and a half years. The transaction is expected to close on July 23, 2025, with proceeds used for working capital an...
07-22 12:30
Amicus Therapeutics will host a conference call and live audio webcast on July 31, 2025, at 8:30 a.m. ET to discuss Q2 2025 financial results. Participants must register online to receive dial-in details, while webcast access is available via the company's Investor Relations website. An archived webcast and slides will be posted shortly after the event.
07-21 11:00
Aemetis (NASDAQ:AMTX) announced Anjaneyulu Ganji as chief financial officer of its India subsidiary, Universal Biofuels, effective July 17, 2025. Ganji's experiences include leading Dodla Dairy’s $450...
07-17 20:19
Aemetis subsidiary Universal Biofuels appoints Anjaneyulu Ganji as Chief Financial Officer to lead expansion in India, focusing on biodiesel, ethanol, and renewable natural gas production. Ganji brings extensive expertise from roles at Dodla Dairy, Marengo Asia Healthcare, and Maersk. Universal Biofuels operates an 80 million gallon biodiesel facility in India and is expanding its biofuels production. Aemetis, based in California, specializes in ...
07-17 12:00
Aemetis CEO Eric McAfee will present at the H.C. Wainwright Annual Global Investment Conference in New York City on September 8-10, 2025. The company highlights its growth projects, including renewable natural gas production, ethanol plant upgrades, carbon sequestration, and a renewable diesel plant. Aemetis benefits from federal and state policies supporting biogas and biofuels, including the One Big Beautiful Bill and California's Low Carbon Fu...
07-16 12:00
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1147088025548091392.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Leerink Partners:维持再鼎医药(ZLAB)"跑赢大市"评级,目标价从73美元升至75美元</p> <p>• 美银证券:维持BioCryst Pharma(BCRX)"买入"评级,目标价从13美元升至15美元
07-02 09:54
美股大行评级 | 巨大分歧!Circle获多家大行首予评级目标价在80~250之间;Stifel上调甲骨文评级至"买入",目标价升至250美元
07-01 09:24
UBS analyst Manav Gupta maintains Aemetis (NASDAQ:AMTX) with a Buy and raises the price target from $2.2 to $3.
07-01 00:55
Aemetis announced the approval of seven LCFS pathways for dairy digesters, with an average carbon intensity of -384. This approval increases LCFS credits by about 100%. The company has eleven digesters in operation and a four-dairy cluster under construction, with additional pathways pending approval. Aemetis also operates several renewable energy projects, including an ethanol plant, a biodiesel facility, a carbon sequestration project, and a su...
06-27 12:00
Gainers Sky Quarry (NASDAQ:SKYQ) shares rose 10.2% to $0.71 during Thursday's ...
06-13 05:05